Under conditions of CCH, the protective effects of TCM could be derived from the synergistic modulation of core signaling pathways such as Nrf2/ARE, NF-κB, and BDNF/CREB by its multiple bioactive components. The gene discussed is CREB1; the disease is columnar cell hyperplasia of the breast.